Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.
cariboubio.com
2929 7th Street, Berkeley, 94710, US
Details
Year founded
2012
Revenue
10M-25M
Employees
51-200
Number of locations
1
NAICS
541714
SIC
8731
Products & Services
Outlines the company's specialized services and operational strengths.
- Allogeneic Cell Therapies
- Armored Cell Therapies
- CRISPR Genome Editing
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- CRISPR genome-editing technology
- chRDNA (CRISPR hybrid RNA-DNA) technology
- CAR-T cell therapy platform
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that caribou biosciences is ramping up production.
Target industries
Employees working in Caribou Biosciences, Inc.
News
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
Caribou Biosciences appoints Dr. Terri Laufer, a seasoned immunologist with 35 years' experience, to boost its autoimmune research and GALLOP clinical...
Locations (1)
Caribou Biosciences, Inc.
2929 7th Street, Berkeley, 94710, US
Frequently Asked Questions
What services & capabilities does Caribou Biosciences, Inc. offer?
Caribou Biosciences, Inc. offers a range of services and capabilities, including Allogeneic Cell Therapies.
What kind of equipment does Caribou Biosciences, Inc. use?
Caribou Biosciences, Inc. uses a variety of equipment, including CRISPR genome-editing technology.
What are the target industries of Caribou Biosciences, Inc.?
Caribou Biosciences, Inc. serves several industries, including the medical industry.
How many locations does Caribou Biosciences, Inc. operate?
Caribou Biosciences, Inc. operates from a single location at 2929 7th street, berkeley, california 94710, united states.
What is the annual revenue of Caribou Biosciences, Inc.?
Caribou Biosciences, Inc.'s revenue is $13.85M.
Where are the headquarters of Caribou Biosciences, Inc.?
The headquarters of Caribou Biosciences, Inc. are located in 2929 7th street, berkeley, california 94710, united states.
What is the NAICS code for Caribou Biosciences, Inc.?
The NAICS code for Caribou Biosciences, Inc. is 541714.
How many employees does Caribou Biosciences, Inc. have?
Caribou Biosciences, Inc. has 137 employees.
What is the official website of Caribou Biosciences, Inc.?
The official website of Caribou Biosciences, Inc. is https://cariboubio.com.
When was Caribou Biosciences, Inc. founded?
Caribou Biosciences, Inc. was founded in 2012.